profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
caroline-pallard,Caroline,Pallard,Statutory Director of NLO Belgium,https://media.licdn.com/dms/image/C4D03AQEWAEB3iRZMgA/profile-displayphoto-shrink_800_800/0/1516892386554?e=1697673600&v=beta&t=ZiTFLON_CgcNNyakMU2HXeZ5kdPUERM6K-zY9Qg0qJE,,personal,ACoAAARSiBYBA4emDLZ-Nn64TDJ7yMfff94rvAk,72517654,,"As a Dutch and European patent attorney I help companies to formulate an IP strategy  in line with their Business strategy. I used to be the Chairwoman of the Supervisory Board at NLO and I also used to be a member of the Advisory Board of SCALE Health. I am currently Statutory director of NLO Belgium.
My technical background is:
- biotechnology, particularly molecular biology
- genomics
- biochemistry
- haematology especially immunology 
- microbiology. 

I often publish articles on European case law. Some examples can be found below.","{'country': 'Netherlands', 'short': 'The Hague, South Holland', 'city': 'The Hague', 'state': 'South Holland', 'default': 'The Hague, South Holland, Netherlands'}",False,False,[],"{'primary_locale': {'country': 'US', 'language': 'en'}, 'supported_locales': [{'country': 'US', 'language': 'en'}], 'profile_languages': [{'name': 'Dutch', 'proficiency': 'NATIVE_OR_BILINGUAL'}, {'name': 'English', 'proficiency': 'FULL_PROFESSIONAL'}, {'name': 'French', 'proficiency': 'NATIVE_OR_BILINGUAL'}]}",Legal Services,"[{'date': {'start': {'month': None, 'day': None, 'year': 2019}, 'end': {'month': None, 'day': None, 'year': 2020}}, 'school': {'name': 'Erasmus University Rotterdam', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQH6a-XX__UABw/company-logo_400_400/0/1564983668078?e=1700697600&v=beta&t=EXGjlpwF6hw4cke4JYowikAr6lRm_EPanhLZJO9VXpk', 'url': 'https://www.linkedin.com/school/erasmus-university-rotterdam/'}, 'degree_name': None, 'field_of_study': 'Business/Commerce, General'}, {'date': {'start': {'month': None, 'day': None, 'year': 1993}, 'end': {'month': None, 'day': None, 'year': 1996}}, 'school': {'name': 'Institut Cochin de Génétique Moléculaire', 'logo': None, 'url': None}, 'degree_name': 'PhD', 'field_of_study': 'Biochemistry and Haematology'}, {'date': {'start': {'month': None, 'day': None, 'year': 1990}, 'end': {'month': None, 'day': None, 'year': 1993}}, 'school': {'name': 'Institut National Agronomique Paris Grignon, INAPG', 'logo': None, 'url': None}, 'degree_name': 'Grande école', 'field_of_study': 'Biotechnology and Biochemistry'}]",[],"[{'title': 'IAM Patent 1000 (2016) recommends NLO', 'description': '""Throughout its 127-year history, NLO has pushed the boundaries of what is possible in terms of patent protection. Prudent investment in new IT solutions and systems have kept the customer experience fresh (though the quality consistent), while its refined commercial sensibilities are something of a rarity among the continent’s patent attorney firms.""', 'issuer': 'IAM Patent 1000', 'date': {'month': 6, 'day': None, 'year': 2016}}]",[],[],[],"[{'name': 'Protection and enforcement of second medical use claims', 'publisher': 'IAM Media Group', 'url': 'http://www.nloinfo.nl/documenten/artikelen/uk/nlo_personalised_medicine_iamlifesciences2016.pdf', 'date': {'month': None, 'day': None, 'year': 2016}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Caroline', 'last_name': 'Pallard', 'name': None, 'headline': 'Statutory Director of NLO Belgium'}, {'type': 'nonStandardizedContributor', 'first_name': None, 'last_name': None, 'name': 'Armand Killan', 'headline': None}]}, {'name': 'Gene patenting and stem-cell related inventions', 'publisher': 'Caroline Pallard and Bart Swinkels', 'url': 'http://www.octrooibureau.nl/documenten/gene_patenting.pdf', 'date': {'month': None, 'day': None, 'year': None}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Caroline', 'last_name': 'Pallard', 'name': None, 'headline': 'Statutory Director of NLO Belgium'}]}, {'name': 'Peptides and Oligonucleotides', 'publisher': 'Caroline Pallard', 'url': 'http://www.octrooibureau.nl/documenten/peptides_and_oligonucleotides_cpd_def.pdf', 'date': {'month': None, 'day': None, 'year': None}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Caroline', 'last_name': 'Pallard', 'name': None, 'headline': 'Statutory Director of NLO Belgium'}]}, {'name': 'The role of the function of dna sequence before and after grant', 'publisher': 'Caroline Pallard and Bart Swinkels', 'url': 'http://www.octrooibureau.nl/documenten/the_role_of_the_function_of_dna_sequence_before_and_after_grant.pdf', 'date': {'month': None, 'day': None, 'year': None}, 'authors': [{'type': 'standardizedContributor', 'first_name': 'Caroline', 'last_name': 'Pallard', 'name': None, 'headline': 'Statutory Director of NLO Belgium'}]}]",[],[],"[{'company': {'id': 42907, 'name': 'NLO', 'logo': 'https://media.licdn.com/dms/image/C4E0BAQFddXbZMCP4Mg/company-logo_400_400/0/1673970693428?e=1700697600&v=beta&t=Cp0n3emgxUX2ZcQFA2i7MwlbP_DN4MzocHKIeENqCfA', 'url': 'https://www.linkedin.com/company/nlo/', 'employees': {'start': 201, 'end': 500}}, 'date': {'start': {'month': 1, 'day': None, 'year': 2006}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'The Hague', 'date': {'start': {'month': 1, 'day': None, 'year': 2006}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'NLO | European patent and trademark attorneys', 'description': 'I became an associate partner in 2008 and a partner in 2012. I have been Chairwoman of the Supervisory Board of NLO during 24 months (2018-2020). \n\nI lead a team of 8 people in biotechnology based in Ghent and Mechelen (BE). We work with start-ups, bigger companies having their own patent department and research institutes. Our clients are based in Europe (the Netherlands, Belgium, France, Spain, Germany, Sweden) and in America. I have extensive experience in drafting and prosecuting complex patent applications (including at the interface between Artificial Intelligence and Biotech). I frequently advise biotech startups on their IP strategies (landscaping study is a middle to help formulating an IP strategy). I am frequently involved in European Opposition Proceedings. I also have experience in supporting complex license negotiations in which IP is pivotal and in advising clients before and during IPO processes (Initial Public Offer). I had been involved in IP mediation.', 'title': 'Partner and Dutch and European patent attorney', 'employment_type': 'Full-time'}]}, {'company': {'id': None, 'name': None, 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 2, 'day': None, 'year': 2021}, 'end': {'month': 12, 'day': None, 'year': 2022}}, 'profile_positions': [{'location': None, 'date': {'start': {'month': 2, 'day': None, 'year': 2021}, 'end': {'month': 12, 'day': None, 'year': 2022}}, 'company': None, 'description': None, 'title': 'Advisory Board of SCALE Health', 'employment_type': 'Self-employed'}]}, {'company': {'id': 3108, 'name': 'DSM / Gist-Brocades', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQH_ii8KbgEPYQ/company-logo_400_400/0/1685542980619?e=1700697600&v=beta&t=fe-S2MZwn5k4GDBelNK3JJCnBRn6rzEx9zKBKnpz3KY', 'url': 'https://www.linkedin.com/company/dsm/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': None, 'day': None, 'year': 1998}, 'end': {'month': None, 'day': None, 'year': 2006}}, 'profile_positions': [{'location': 'Delft Area, Netherlands', 'date': {'start': {'month': None, 'day': None, 'year': 1998}, 'end': {'month': None, 'day': None, 'year': 2006}}, 'company': 'DSM', 'description': 'I was responsible of the IP strategy of different business units over the years: from fermentation technology using Aspergillus niger to probiotics or cheese coating.', 'title': 'European and Dutch patent attorney', 'employment_type': None}]}, {'company': {'id': 8373242, 'name': 'The Netherlands Cancer Institute', 'logo': 'https://media.licdn.com/dms/image/C560BAQEqz4HPV21a-Q/company-logo_400_400/0/1519888856405?e=1700697600&v=beta&t=6LwviCLR9ot0UlsGa7_yMD8XGO1pCYnLRKV2nECIf6s', 'url': 'https://www.linkedin.com/company/the-netherlands-cancer-institute/', 'employees': {'start': 1001, 'end': 5000}}, 'date': {'start': {'month': None, 'day': None, 'year': 1996}, 'end': {'month': None, 'day': None, 'year': 1998}}, 'profile_positions': [{'location': 'Amsterdam Area, Netherlands', 'date': {'start': {'month': None, 'day': None, 'year': 1996}, 'end': {'month': None, 'day': None, 'year': 1998}}, 'company': 'The Netherlands Cancer Institute', 'description': 'Postdoctoral fellow, focused on immunology and biochemistry: I studied the signal transduction of human IL-7 in early human T cell differentiation.', 'title': 'Postdoctoral EMBO fellowship', 'employment_type': 'Full-time'}]}]",[],"['Biotechnology', 'Molecular Biology', 'Genomics', 'Biochemistry', 'Immunology', 'Microbiology', 'Drafting and Prosecuting Patent Applications', 'Supporting IP Licence Negotiations', 'Intellectual Property', 'Patent Prosecution', 'Technology Transfer', 'Patents', 'Pharmaceutical Industry', 'Patent Litigation', 'Patentability', 'Licensing', 'Prosecution', 'R&D', 'Life Sciences']",,,
